Family Office Real Estate Daily · Family Office Real Estate Research Desk · Preview
Research Desk
A curated index of 20,204 CRE market research reports from the major institutional publishers — filterable by asset class, market and publisher. Editorial Family-Office interpretation layer is rolling out report-by-report.
Showing Family Office Briefings with a LP angle — each card surfaces how a family office could deploy capital in that market.
24 reports
Page 1 / 1- TranswesternMay 15, 2026
US Life Sciences Market Research Report - Q1 2026
LP:Family offices may also consider passive LP commitments in funds focused on late-stage life sciences investments.
- TranswesternMar 9, 2026
Houston Life Sciences Research Report - H1 2026
LP:As a passive LP, a family office could commit to funds focused on the burgeoning life sciences sector in Houston.
- TranswesternFeb 6, 2026
US Life Sciences Market Research Report - Q4 2025
LP:Family offices may also consider passive LP commitments in life sciences funds, although this is the least emphasized strategy.
- TranswesternNov 3, 2025
US Life Sciences Market Research Report - Q3 2025
LP:Family offices may also consider passive LP commitments in life sciences funds, although this is the least emphasized strategy.
- TranswesternSep 12, 2025
Houston Life Sciences Research Report - Summer-Fall 2025
LP:Family offices may also consider passive LP commitments in funds targeting life sciences investments to gain exposure without operational involvement.
- TranswesternAug 15, 2025
US Life Sciences Market Research Report - Q2 2025
LP:As a passive LP, a family office could commit to funds focused on life sciences, benefiting from the sector's recovery while minimizing direct involvement.
- TranswesternJun 6, 2025
US Life Sciences Market Research Report - Q1 2025
LP:Family offices may also consider passive LP commitments in funds focused on life sciences to gain exposure without direct management.
- TranswesternApr 7, 2025
US Life Sciences Market Research Report - Q4 2024
LP:Family offices may also consider passive LP commitments in funds focused on life sciences to gain exposure without direct management responsibilities.
- TranswesternMar 14, 2025
Houston Life Sciences Research Report - Winter-Spring 2025
LP:Family offices could also consider passive LP commitments in funds targeting Houston's life sciences sector.
- TranswesternFeb 7, 2025
San Francisco Life Science Research Report - Q4 2024
LP:As a passive LP, a family office could commit to funds focused on life sciences, benefiting from the sector's growth without direct operational involvement.
- TranswesternJan 17, 2025
US Life Sciences Market Research Report - Q3 2024
LP:As a passive LP, a family office could commit to funds focused on life sciences, although this is the least emphasized strategy.
- TranswesternOct 18, 2024
San Francisco Life Science Research Report - Q2 2024
LP:As a passive LP, a family office could commit to funds focused on life sciences, although this approach offers less control and alignment.
- TranswesternSep 16, 2024
US Life Sciences Market Research Report - Q2 2024
LP:As a passive LP, a family office could commit to funds focused on life sciences, benefiting from the sector's growth without direct operational involvement.
- TranswesternSep 13, 2024
Houston Life Sciences Research Report - Summer-Fall 2024
LP:Family offices may also consider passive LP commitments in funds focused on Houston's life sciences opportunities.
- TranswesternJun 7, 2024
US Life Sciences Market Research Report - Q1 2024
LP:As a passive LP, a family office could commit capital to a life sciences fund, gaining exposure to the sector's growth without direct management responsibilities.
- TranswesternJun 7, 2024
Houston Life Sciences Research Report - Winter-Spring 2024
LP:Family offices can also consider passive LP commitments in funds focused on Houston's life sciences sector to gain exposure without direct management responsibilities.
- TranswesternApr 19, 2024
US Life Sciences Market Research Report - Q4 2023
LP:As a passive LP, a family office could commit capital to a life sciences fund, gaining exposure to the sector without direct management responsibilities.
- TranswesternFeb 16, 2024
Bay Area Life Sciences Research Report - Q4 2023
LP:As a passive LP, a family office could commit to funds focused on life sciences, although this is the least emphasized strategy.
- TranswesternDec 15, 2023
US Life Sciences Market Research Report - Q3 2023
LP:As a passive LP, a family office can gain exposure to life sciences through established funds, though this is the least emphasized strategy.
- TranswesternNov 10, 2023
Bay Area Life Sciences Research Report - Q3 2023
LP:Family offices may also consider passive LP commitments in life sciences funds, although this is the least emphasized strategy.
- TranswesternSep 15, 2023
Houston Life Science Research Report - Summer-Fall 2023
LP:Family offices may also consider passive LP commitments in funds targeting life sciences ventures to gain exposure to the market.
- TranswesternAug 4, 2023
Bay Area Life Sciences Research Report - Q2 2023
LP:As a passive LP, a family office could commit to a fund focused on life sciences, although this may offer less alignment with operators compared to co-GP structures.
- TranswesternApr 28, 2023
Bay Area Life Sciences Research Report - Q1 2023
LP:As a passive LP, a family office could commit to a fund focused on life sciences, although this is the least emphasized strategy.
- TranswesternApr 28, 2023
Houston Life Science Research Report - Winter-Spring 2023
LP:Family offices may also consider passive LP commitments in funds focused on Houston's life sciences sector to gain exposure without direct management responsibilities.
Research Hubs
Dedicated pages for every major publisher and market — each with aggregated KPI medians, asset-class breakdowns and the latest reports, read through a family-office lens.